At the end of 2017, Herb (an organic polymer chemist) and Nico (healthcare business professional) were walking their dogs and chatting on how it would be great if they could somehow pool their experience to setup a business venture. They already had a strong neighbourhood relation for many years and both Nico and Herb were tied to the healthcare markets; Nico from the business side and Herb from the technical side.
At this point, Herb mentioned that he had an idea of how to produce a class of biocidal polymers that were simple to manufacture and were based on an active system that had long been used and accepted in healthcare. Nico, being intimately connected with the healthcare sector and knowing the immense problems that infections cause in the industry (both from a health and financial side), immediately said “let’s try it” and that was the start of X-Infex B.V.
The first development trials were conducted in Norway in May of 2018 just to see if the idea was feasible. Both the trials and subsequent bacterial testing showed the new materials could be manufactured and showed desired biocidal activity. This led to additional trials and testing that finally culminated in the filing of two patents. Though the initial focus for the invention was medical devices (i.e. device used for a medical purpose such as urinary catheters, deep lines, sutures, drains, wound dressings, etc.), it quickly became obvious that the potential applications and interest was much larger. Hugo joined X-Infex the end of 2018 to offer his industrial experience and know-how to broaden the reach of X-Infex’s customer base.
X-Infex now works with a number of interested parties to assess and incorporate the technology in a broad range of medical devices, consumer healthcare and industrial products. The practicality of the technology coupled with the ease to scale-up and manufacture makes the X-Infex technology interesting to evaluate in both price sensitive and healthcare driven markets. In the end, it is the goal of X-Infex to offer solutions and products that can better peoples’ health, no matter where they may live.
In 2018, X-Infex was founded by a team of result-driven entrepreneurs. With a mix of technical know-how, strong application focus in various industries, and a total of more than 75 years of experience in the medical industry, X-Infex’s Executive Team aims to revolutionise the industry and make impact on a global scale.